AMENDMENT NO. 1 TO FOUNDER COMMON STOCK PURCHASE AGREEMENTFounder Common Stock Purchase Agreement • June 12th, 2015 • Viking Therapeutics, Inc. • Pharmaceutical preparations • California
This Amendment No. 1 to Founder Common Stock Purchase Agreement (this “Amendment”) is made as of May 4, 2015, by and between Viking Therapeutics, Inc., a Delaware corporation (the “Company”), and Brian Lian, Ph.D. (“Purchaser”).
VIKING THERAPEUTICS, INC. FOUNDER COMMON STOCK PURCHASE AGREEMENTFounder Common Stock Purchase Agreement • July 1st, 2014 • Viking Therapeutics, Inc. • Pharmaceutical preparations • California
As escrow agent (“Escrow Agent”) for both Viking Therapeutics, Inc., a Delaware corporation (together with its successors or assigns, the “Company”), and Brian Lian (“Purchaser”), you are hereby authorized and directed to hold the documents delivered to you pursuant to the terms of that certain Viking Therapeutics, Inc. Founder Common Stock Purchase Agreement, by and between the Company and Brian Lian, dated as of the date hereof (the “Agreement”), to which a copy of these Joint Escrow Instructions is attached, in accordance with the following instructions (capitalized terms used but not defined in these Joint Escrow Instructions shall have the meanings assigned thereto in the Agreement):
